Literature DB >> 29551751

Bone turnover markers after the menopause: T-score approach.

Fatma Gossiel1, Hibatallah Altaher1, David M Reid2, Christian Roux3, Dieter Felsenberg4, Claus-C Glüer5, Richard Eastell6.   

Abstract

Bone turnover increases at the menopause and is associated with accelerated bone loss. However, it is not known to what extent there is an imbalance between the processes of bone resorption and bone formation, nor whether it is the rate of bone turnover or the bone balance that is most closely associated with the rate of bone loss. We studied 657 healthy women ages 20 to 79 from five European cities (the OPUS Study) and divided them into two premenopausal age groups, 20 to 29 (n=129), 30 to 39years (n=183), and three postmenopausal groups 1 to 10years (n=91), 11 to 20years (n=131) and 21+ years since menopause (n=123). We measured collagen type I C-telopeptide (CTX, a marker of bone resorption) and procollagen I N-propeptide (PINP, a marker of bone formation). We used these two markers to calculate the overall bone turnover and the difference between bone formation and resorption (bone balance) using the results from the women ages 30 to 39years to calculate a standardised score (T-score). We found that the CTX and PINP levels were higher in the women ages 20 to 29 and in the women in the three menopausal groups as compared to women ages 30 to 39years (p<0.001). For example, the CTX and PINP levels were 80 and 33% higher in women 1 to 10years since menopause as compared to women ages 30 to 39years. In this group of postmenopausal women, the bone turnover expressed as a T-score was 0.72 (0.57 to 0.88, 95%CI) and the bone balance was -0.37 (-0.59 to -0.16). There was greater rate of bone loss from the total hip in all the groups of women after the menopause compared to women before the menopause. We conclude that the bone loss after the menopause is associated with both an increase in bone turnover and a negative bone balance and that bone loss was most clearly associated with overall bone turnover.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone mineral density; Bone turnover markers; Menopause; Osteoporosis

Mesh:

Substances:

Year:  2018        PMID: 29551751     DOI: 10.1016/j.bone.2018.03.016

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  15 in total

1.  Association between changes in bioactive osteocalcin and glucose homeostasis after biliopancreatic diversion.

Authors:  Anne-Frédérique Turcotte; Thomas Grenier-Larouche; Julie Lacombe; Anne-Marie Carreau; André C Carpentier; Fabrice Mac-Way; André Tchernof; Denis Richard; Laurent Biertho; Stefane Lebel; Simon Marceau; Mathieu Ferron; Claudia Gagnon
Journal:  Endocrine       Date:  2020-05-17       Impact factor: 3.633

2.  Faster Lumbar Spine Bone Loss in Midlife Predicts Subsequent Fracture Independent of Starting Bone Mineral Density.

Authors:  Albert Shieh; Arun S Karlamangla; Mei-Hua Huang; Weijuan Han; Gail A Greendale
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

3.  The gut microbiome is associated with bone turnover markers in postmenopausal women.

Authors:  Lin Chen; Shuai Yan; Ming Yang; Fudong Yu; Jingjing Wang; Xiaoxin Wang; Huanbai Xu; Jianxia Shi; Ling Pan; Yuexi Zeng; Siyu Li; Li Li; Li You; Yongde Peng
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

4.  The Association between Fast Increase in Bone Turnover During the Menopause Transition and Subsequent Fracture.

Authors:  Albert Shieh; Gail A Greendale; Jane A Cauley; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 6.134

5.  Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE.

Authors:  R Eastell; B H Mitlak; Y Wang; M Hu; L A Fitzpatrick; D M Black
Journal:  Osteoporos Int       Date:  2019-01-11       Impact factor: 4.507

6.  Predictors of fragility fracture and low bone mineral density in patients with a history of parental fracture.

Authors:  Mrinalini Dey; Marwan Bukhari
Journal:  Osteoporos Sarcopenia       Date:  2019-03-15

7.  The use of bone turnover markers for monitoring the treatment of osteoporosis in postmenopausal females undergoing total knee arthroplasty: a prospective randomized study.

Authors:  Rui Ma; Mengjun Wu; Yongwei Li; Jialin Wang; Pei Yang; Yuanyuan Chen; Wei Wang; Jinhui Song; Kunzheng Wang
Journal:  J Orthop Surg Res       Date:  2021-03-17       Impact factor: 2.359

8.  p53 plays a central role in the development of osteoporosis.

Authors:  Tao Yu; Xiaomeng You; Haichao Zhou; Alex Kang; Wenbao He; Zihua Li; Bing Li; Jiang Xia; Hui Zhu; Youguang Zhao; Guangrong Yu; Yuan Xiong; Yunfeng Yang
Journal:  Aging (Albany NY)       Date:  2020-06-02       Impact factor: 5.682

9.  Correlation between Urine N-Terminal Telopeptide and Fourier Transform Infrared Spectroscopy Parameters: A Preliminary Study.

Authors:  Ichiro Okano; Stephan N Salzmann; Courtney Ortiz Miller; Colleen Rentenberger; Paul Schadler; Oliver C Sax; Jennifer Shue; Andrew A Sama; Frank P Cammisa; Federico P Girardi; Alexander P Hughes
Journal:  J Osteoporos       Date:  2020-02-11

10.  Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study.

Authors:  Xiao-Long Qu; Bo Zheng; Tian-Yi Chen; Zong-Rui Cao; Bo Qu; Tao Jiang
Journal:  Orthop Surg       Date:  2019-12-27       Impact factor: 2.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.